HIV therapy, metabolic and cardiovascular health are associated with glomerular hyperfiltration among men with and without HIV infection

AIDS

Volumn 28, Issue 3, 2014, Pages 377-386

  Ng, Derek K ^a   Jacobson, Lisa P ^a   Brown, Todd T ^a,b   Palella Jr , Frank J ^c   Martinson, Jeremy J ^d   Bolan, Robert ^e   Miller III, Edgar R ^a,b,f   Schwartz, George J ^g   Abraham, Alison G ^a   Estrella, Michelle M ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NORTHWESTERN UNIVERSITY   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e LOS ANGELES LGBT CENTER   (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Antiretroviral therapy; Glomerular filtration rate; Glomerular hyperfiltration; HIV; Iohexol

Indexed keywords

ADULT; ANTI-RETROVIRAL AGENTS; COHORT STUDIES; GLOMERULAR FILTRATION RATE; HEALTH; HIV; HIV INFECTIONS; HUMANS; KIDNEY; KIDNEY DISEASES; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEINURIA;

EID: 84894073434     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0000000000000094     Document Type: Article

References (47)

1. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338:853-860.
2. Wada N, Jacobson LP, Cohen M, French A, Phair J, Muñoz A. Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol 2013; 177:116-125.
3. Adih WK, Selik RM, Hu X. Trends in diseases reported on US death certificates that mentioned HIV infection, 1996-2006. J Int Assoc Physicians AIDS Care (Chic) 2011; 10:5-11.
4. Wyatt CM, Morgello S, Katz-Malamed R, Wei C, Klotman ME, Klotman PE, et al. The spectrum of kidney disease in patients with AIDS in the era of antiretroviral therapy. Kidney Int 2009; 75:428-434.
5. Brown TT, Cole SR, Li X, Kingsley LA, Palella FJ, Riddler SA, et al. Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med 2005; 165:1179-1184.
6. George E, Lucas GM, Nadkarni GN, Fine DM, Moore R, Atta MG. Kidney function and the risk of cardiovascular events in HIV-1-infected patients. AIDS 2010; 24:387-394.
7. Brenner BM, Lawler EV, Mackenzie HS. The hyperfiltration theory: a paradigm shift in nephrology. Kidney Int 1996; 49: 1774-1777.
8. Chaiken RL, Eckert-Norton M, Bard M, Banerji MA, Palmisano J, Sachimechi I, et al. Hyperfiltration in African-American patients with type 2 diabetes. Cross-sectional and longitudinal data. Diabetes Care 1998; 21:2129-2134.
9. Tomaszewski M, Charchar FJ, Maric C, McClure J, Crawford L, Grzeszczak W, et al. Glomerular hyperfiltration: a new marker of metabolic risk. Kidney Int 2007; 71:816-821.
10. Helal I, Fick-Brosnahan GM, Reed-Gitomer B, Schrier RW. Glomerular hyperfiltration: definitions, mechanisms and clinical implications. Nat Rev Nephrol 2012; 8:293-300.
11. Ruggenenti P, Porrini EL, Gaspari F, Motterlini N, Cannata A, Carrara F, et al. Glomerular hyperfiltration and renal disease progression in type 2 diabetes. Diabetes Care 2012; 35:2061- 2068.
12. Melsom T, Mathisen UD, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, et al. Impaired fasting glucose is associated with renal hyperfiltration in the general population. Diabetes Care 2011; 34:1546-1551.
13. Okada R, Yasuda Y, Tsushita K, Wakai K, Hamajima N, Matsuo S. Glomerular hyperfiltration in prediabetes and prehypertension. Nephrol Dial Transplant 2012; 27:1821-1825.
14. Tebas P. Insulin resistance and diabetes mellitus associated with antiretroviral use in HIV-infected patients: pathogenesis, prevention, and treatment options. J Acquir Immune Defic Syndr 2008; 49:S86-S92.
15. Vu CN, Ruiz-Esponda R, Yang E, Chang E, Gillard B, Pownall HJ, et al. Altered relationship of plasma triglycerides to HDL cholesterol in patients with HIV/HAART-associated dyslipidemia: further evidence for a unique form of metabolic syndrome in HIV patients. Metab Clin Exp 2013; 62:1014- 1020.
16. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987; 126:310-318.
17. Schwartz GJ, Furth S, Cole SR, Warady B, Muñoz A. Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int 2006; 69:2070- 2077.
18. Schwartz GJ, Abraham AG, Furth SL, Warady BA, Muñoz A. Optimizing iohexol plasma disappearance curves to measure the glomerular filtration rate in children with chronic kidney disease. Kidney Int 2010; 77:65-71.
19. Ng DKS, Schwartz GJ, Jacobson LP, Palella FJ, Margolick JB, Warady BA, et al. Universal GFR determination based on two time points during plasma iohexol disappearance. Kidney Int 2011; 80:423-430.
20. Caliendo AM, Valsamakis A, Zhou Y, Yen-Lieberman B, Andersen J, Young S, et al. Multilaboratory comparison of hepatitis C virus viral load assays. J Clin Microbiol 2006; 44:1726- 1732.
21. Hultin LE, Menendez FA, Hultin PM, Jamieson BD, O'Gorman MRG, Borowski L, et al. Assessing immunophenotyping performance: proficiency-validation for adopting improved flow cytometrymethods. Cytometry B Clin Cytom2007; 72:249-255.
22. Premaratne E, Macisaac RJ, Tsalamandris C, Panagiotopoulos S, Smith T, Jerums G. Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate. Diabetologia 2005; 48:2486-2493.
23. Palatini P. Glomerular hyperfiltration: a marker of early renal damage in prediabetes and prehypertension. Nephrol Dial Transplant 2012; 27:1708-1714.
24. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002; 39:S1-S266.
25. Mondy K, Overton ET, Grubb J, Tong S, Seyfried W, Powderly W, et al. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population. Clin Infect Dis 2007; 44:726-734.
26. Curran A, Ribera E. From old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir. Expert Opin Drug Saf 2011; 10:389-406.
27. Kalyesubula R, Perazella MA. Nephrotoxicity of HAART. AIDS Res Treat 2011; 2011:562790.
28. Crowe AV, Howse M, Bell GM, Henry JA. Substance abuse and the kidney. QJM 2000; 93:147-152.
29. Maeda I, Hayashi T, Sato KK, Koh H, Harita N, Nakamura Y, et al. Cigarette smoking and the association with glomerular hyperfiltration and proteinuria in healthy middle-aged men. Clin J Am Soc Nephrol 2011; 6:2462-2469.
30. Shoptaw S, Stall R, Bordon J, Kao U, Cox C, Li X, et al. Cumulative exposure to stimulants and immune function outcomes among HIV-positive and HIV-negative men in the Multicenter AIDS Cohort Study. Int J STD AIDS 2012; 23:576-580.
31. Mateen FJ, Shinohara RT, Carone M, Miller EN, McArthur JC, Jacobson LP, et al. Neurologic disorders incidence in HIVR vs. HIV- men: Multicenter AIDS Cohort Study, 1996-2011. Neurology 2012; 79:1873-1880.
32. Jerums G, Premaratne E, Panagiotopoulos S, MacIsaac RJ. The clinical significance of hyperfiltration in diabetes. Diabetologia 2010; 53:2093-2104.
33. Bruggeman LA, Ross MD, Tanji N, Cara A, Dikman S, Gordon RE, et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol 2000; 11:2079-2087.
34. Lu T-C, He JC, Klotman PE. Podocytes in HIV-associated nephropathy. Nephron Clin Pract 2007; 106:c67-c71.
35. Chandel N, Sharma B, Husain M, Salhan D, Singh T, Rai P, et al. HIV compromises integrity of podocyte actin cytoskeleton through down regulation of vitamin D receptor. Am J Physiol Renal Physiol 2013; 304:F1347-F1357.
36. Congote LF. Monitoring insulin-like growth factors in HIV infection and AIDS. Clin Chim Acta 2005; 361:30-53.
37. Rao MN, Mulligan K, Tai V, Wen MJ, Dyachenko A, Weinberg M, et al. Effects of insulin-like growth factor (IGF)-I/IGF-binding protein-3 treatment on glucose metabolism and fat distribution in human immunodeficiency virus-infected patients with abdominal obesity and insulin resistance. J Clin Endocrinol Metab 2010; 95:4361-4366.
38. Okada R, Wakai K, Naito M, Morita E, Kawai S, Yin G, et al. Renal hyperfiltration in prediabetes confirmed by fasting plasma glucose and hemoglobin A1c. Ren Fail 2012; 34:1084-1090.
39. Schmieder RE, Veelken R, Gatzka CD, Ru?ddel H, Schächinger H. Predictors for hypertensive nephropathy: results of a 6-year follow-up study in essential hypertension. J Hypertens 1995; 13:357-365.
40. Palatini P, Mos L, Ballerini P, Mazzer A, Saladini F, Bortolazzi A, et al. Relationship between GFR and albuminuria in stage 1 hypertension. Clin J Am Soc Nephrol 2013; 8:59-66.
41. Medapalli RK, Parikh CR, Gordon K, Brown ST, Butt AA, Gibert CL, et al. Comorbid diabetes and the risk of progressive chronic kidney disease in HIV-infected adults: data from the Veterans Aging Cohort Study. J Acquir Immune Defic Syndr 2012; 60:393-399.
42. Choi AI, Rodriguez RA, Bacchetti P, Bertenthal D, Volberding PA, O'Hare AM. Racial differences in end-stage renal disease rates in HIV infection versus diabetes. J Am Soc Nephrol 2007; 18:2968-2974.
43. Wierup N, Björkqvist M, Kuhar MJ, Mulder H, Sundler F. CART regulates islet hormone secretion and is expressed in the betacells of type 2 diabetic rats. Diabetes 2006; 55:305-311.
44. Banke E, Riva M, Shcherbina L, Wierup N, Degerman E. Cocaine- and amphetamine-regulated transcript is expressed in adipocytes and regulate lipid- and glucose homeostasis. Regul Pept 2013; 182:35-40.
45. Kotchen TA, Piering AW, Cowley AW, Grim CE, Gaudet D, Hamet P, et al. Glomerular hyperfiltration in hypertensive African Americans. Hypertension 2000; 35:822-826.
46. Nelson RG, Bennett PH, Beck GJ, Tan M, Knowler WC, Mitch WE, et al. Development and progression of renal disease in Pima Indians with noninsulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N Engl J Med 1996; 335:1636-1642.
47. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med 2006; 354:2473-2483.